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Background:  At least 200,000 patients in the United States suffer venous thromboembolism (VTE) every year, and 19% of cases are fatal. The 
D-dimer test(DD) has shown excellent sensitivity (88-97%), but poor specificity (43-69%). We hypothesized that a positive DD increases utilization of 
CT angiography with venous phase (CTAV) leading to decreased diagnostic yield and increased cost.
Methods:  We conducted a retrospective analysis of patients who underwent CTAV in the Emergency Department at the Medical College of Georgia 
from 08/04 to 07/05. We included 359 consecutive patients who had CTAV for suspected VTE based on positive DD (Group1) or clinical suspicion 
(Group 2). We reviewed available history, physical examination and investigations for VTE. The modified Well’s score was used to subdivide the groups 
into high Well’s (score >4) and low Well’s (score ≤4). Actual billed costs were used for cost analysis. The primary objective was to compare the cost 
per positive diagnosis. Subgroup analysis was performed for both cost and yield.
Results:  
Conclusions:  Despite the known limitations of DD, group 1 had the highest CTAV yield and the lowest per positive diagnosis cost. The clinical 
suspicion group had more than 50% increased cost per positive diagnosis. The significance of DD was further highlighted as 85% of group 1 had 
low Well’s score (≤4). Among the patients who had CTAV after a negative DD ( N=22), none had VTE.A screening DD may result in cost saving in a low 
prevailance cohort for VTE.
